Potential clinical utility of polymerase chain reaction in microbiological testing for sepsis

Critical Care Medicine

Volumn 37, Issue 12, 2009, Pages 3085-3090

  Lehmann, Lutz Eric ^a,f   Alvarez, Julian ^b   Hunfeld, Klaus Peter ^c   Goglio, Antonio ^d   Kost, Gerald J ^e   Louie, Richard F ^e   Raglio, Annibale ^d   Regueiro, Benito J ^b   Wissing, Heimo ^c   Stüber, Frank ^f  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^d OSPEDALI RIUNITI   (Italy)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF BERN   (Switzerland)

Author keywords

Adequate treatment; Gainable days; Inadequate antimicrobials; Rapid pathogen detection

Indexed keywords

ADULT; AGED; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; ASPERGILLUS FUMIGATUS; BLOOD CULTURE; BLOOD SAMPLING; CANDIDA; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; ENTEROBACTER; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FEMALE; GENERAL HOSPITAL; GERMANY; HUMAN; INTENSIVE CARE; ITALY; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MICROBIAL IDENTIFICATION; MICROBIOLOGICAL EXAMINATION; MULTICENTER STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; REDUCTION; SEPSIS; SERRATIA MARCESCENS; SPAIN; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIAE; SURGICAL WARD; TERTIARY HEALTH CARE; TREATMENT DURATION; UNITED STATES; UNIVERSITY HOSPITAL; ADOLESCENT; MICROBIOLOGY; MIDDLE AGED; POLYMERASE CHAIN REACTION;

ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; SEPSIS; YOUNG ADULT;

EID: 73349137967     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181b033d7     Document Type: Article

References (30)

1. Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554
2. Dellinger RP, Carlet JM, Masur H, et al: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32:858-873 (Pubitemid 38344143)
3. Gao F, Melody T, Daniels DF, et al: The impact of compliance with 6-hour and 24hour sepsis bundles on hospital mortality in patients with severe sepsis: A prospective observational study. Crit Care 2005; 9:R764-R770
4. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
5. Kumar A, Roberts D, Wood KE, et al: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589-1596
6. Harbarth S, Nobre V, Pittet D: Does antibiotic selection impact patient outcome? Clin Infect Dis 2007; 44:87-93
7. Ibrahim EH, Sherman G, Ward S, et al: The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146-155
8. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, et al: Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003; 31:2742-2751
9. Leibovici L, Shraga I, Drucker M, et al: The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244:379-386
10. Peters RP, van Agtmael MA, Danner SA, et al: New developments in the diagnosis of bloodstream infections. Lancet Infect Dis 2004; 4:751-760
11. American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
12. Louie RF, Tang Z, Albertson TE, et al: Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia. Crit Care Med 2008; 36:1487-1492
13. Lehmann LE, Hunfeld KP, Emrich T, et al: A multiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples. Med Microbiol Immunol 2008; 197:313-324
14. Kane TD, Alexander JW, Johannigman JA: The detection of microbial DNA in the blood: A sensitive method for diagnosing bactere-mia and/or bacterial translocation in surgical patients. Ann Surg 1998; 227:1-9
15. Ley BE, Linton CJ, Bennett DM, et al: Detection of bacteraemia in patients with fever and neutropenia using 16S rRNA gene amplification by polymerase chain reaction. Eur J Clin Microbiol Infect Dis 1998; 17:247-253
16. Relman DA, Schmidt TM, MacDermott RP, et al: Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 1992; 327:293-301
17. Wilson KH, Blitchington R, Frothingham R, et al: Phylogeny of the Whipple's disease-associated bacterium. Lancet 1991; 338: 474-475
18. Peters RP, Savelkoul PH, Simoons-Smit AM, et al: Faster identification of pathogens in positive blood cultures by fluorescence in situ hybridization in routine practice. J Clin Microbiol 2006; 44:119-123
19. Cleven BE, Palka-Santini M, Gielen J, et al: Identification and characterization of bacterial pathogens causing bloodstream infections by DNA microarray. J Clin Microbiol 2006; 44:2389-2397
20. Mothershed EA, Whitney AM: Nucleic acid-based methods for the detection of bacterial pathogens: Present and future considerations for the clinical laboratory. Clin Chim Acta 2006; 363:206-220
21. Schrenzel J: Clinical relevance of new diagnostic methods for bloodstream infections. Int J Antimicrob Agents 2007; 30(Suppl 1): S2-S6
22. Fenollar F, Raoult D: Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria. Int J Antimicrob Agents 2007; 30(Suppl 1):S7-S15
23. Vincent JL, Sakr Y, Sprung CL, et al: Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 2006; 34: 344-353
24. Dellit TH, Owens RC, McGowan JE Jr, et al: Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44: 159-177
25. Kang CI, Kim SH, Park WB, et al: Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: Risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005; 49: 760-766
26. Kollef MH, Sherman G, Ward S, et al: Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients. Chest 1999; 115:462-474
27. Corless CE, Guiver M, Borrow R, et al: Contamination and sensitivity issues with a realtime universal 16S rRNA PCR. J Clin Micro-biol 2000; 38:1747-1752
28. Meier A, Persing DH, Finken M, et al: Elimination of contaminating DNA within poly-merase chain reaction reagents: Implications for a general approach to detection of uncultured pathogens. J Clin Microbiol 1993; 31: 646-652
29. Nikkari S, Gotoff R, Bourbeau PP, et al: Identification of Cardiobacterium hominis by broad-range bacterial polymerase chain reaction analysis in a case of culture-negative endocarditis. Arch Intern Med 2002; 162: 477-479
30. Garnacho-Montero J, Ortiz-Leyba C, Herrera-Melero I, et al: Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: A matched cohort study. J Antimicrob Chemother 2008; 61:436-441